I remain optimistic that the worm will turn Wednes
Post# of 148168
Plenty of room in Covid for therapeutics even if a vaccine and anti-viral prove effective.
I would loose to see Biocryst succeed. Galidesevir appears to be a nucleotide analog that actually works.
It’s success would be the biggest direct kick to Gilead until Cytodyn steals the Gilead market share for HIV.